The origin of the production of diphtheria antitoxin in France: between philanthropy and commerce
Abstract
Serotherapy for the treatment of diphtheria represented a major therapeutic innovation at the end of the nineteenth century. The manner in which large-scale production of this medicament was undertaken and the regulations that governed its production and distribution were important elements of public health policy in France as in other European countries. This paper describes the dominance of the Pasteur Institute in this field and, starting from this observation, explores what this event in the history of medicine can tell us about the governance of public health in fin-de-siècle France. The particular organization of this institute and its monopoly of specialist microbiological knowledge allowed it to raise money for serum production from both private and public sources, walking the line between a commercial pharmaceutical venture and a philanthropic enterprise.
References
Behring, E. y Kitasato, S. (1890). Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren. Deutsche Medicinische Wochenschrift, 16 (49), 1113–1114.
Chauveau, S. (1999). L’invention pharmaceutique. La pharmacie française entre l’Etat et la société au XX° siècle. París: Institut d’Edition Sanofi-Synthélabo.
Geoffroy, H. y Levassort, C. (1912). Les Sérums et la loi. Clermont: Syndicat des Médecins de la Seine, p. 36.
Gradmann, Ch. (2005). Krankheit im Labor. Robert Koch und die medizinische Bakteri- ologie. Göttingen.
Hardy, A. I. (2006). Paul Ehrlich and commercial serum production: on the control of diphtheria antitoxin in the laboratory and in industry. Medizinhistorisches Journal, 41, 1, pp. 51–84.
Latour, B. (1984). Les Microbes : guerre et paix. París: A.-M. Métaillé.
Löwy, I. (1994). On hybridizations, networks and new disciplines: The Pasteur Institute and the development of microbiology in France. Studies in the History and Philos- ophy of Science, 25, pp. 655–688.
Martin, L. (1897). Production de la toxine diphtérique. [Tesis de Medicina], Facultad de Medicina, París.
Roux, E. y Yersin, A. (1888). Contribution à l’étude de la diphthérie. Annales de l’Institut Pasteur, 629–661.
Schulte, E. (2000). Der Anteil Erich Wernickes and der Entwicklung des Diphtherieanti- toxins [Tesis de Medicina], FreeUniversity, Berlín.
Thrum, C. (1995). Das Diphtherie-Serum: Ein neues Therapieprinzip, seine Entwicklung und Markteinführung, Stuttgart: Wissenschaftliche Verlagsgesellschaft.
Weisz, G. (1995). The Medical Mandarins: The French Academy of Medicine in the Nine- teenth and Early Twentieth Centuries. Oxford: Oxford University Press.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Revista Latinoamericana de Estudios Críticos Animales
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La Revista Latinoamericana de Estudios Críticos Animales con ISSN 2346-920X se adhiere a las diferentes iniciativas que promueven el acceso libre al conocimiento, por lo que todos los contenidos de la misma son de acceso libre y gratuito y publicados bajo la licencia Creative Commons, que permite su difusión pero impide la alteración de la obra e incluye siempre mención al autor/a y fuente.
Es decir, una licencia de tipo Atribución-NoComercial-SinObraDerivada.
Por ello, los correos electrónicos de los autores se encontrarán a disposición de los lectores, en caso de que deseen contactarlos personalmente.
